Author name: comtex

Anika Reports Second Quarter 2025 Financial Results

(NASDAQ:ANIK), Regenerative Solutions revenue up 41% with Integrity(TM) Implant System ahead of expectations and continued strong Hyalofast(R) growth; Integrity surpasses full year 2024 performance and is on pace to more than double in 2025 Company released topline results for Hyalofast(R) clinical trial which did not meet pre-specified co-primary end points; Hyalofast demonstrated statistically significant improvements […]

Anika Reports Second Quarter 2025 Financial Results

Anika Reports Second Quarter 2025 Financial Results GlobeNewswire July 30, 2025 Regenerative Solutions revenue up 41% with Integrity(TM) Implant System ahead of expectations and continued strong Hyalofast(R) growth; Integrity surpasses full year 2024 performance and is on pace to more than double in 2025 Company released topline results for Hyalofast(R) clinical trial which did not

Aurora Cannabis Inc. Reminds Shareholders to Vote in Advance of the Proxy Voting Deadline for its 2025 Annual General and Special Meeting of Shareholders

— Your vote is important no matter how many shares you own. Please vote today. — Shareholders who have questions or need assistance with voting their shares should contact Aurora's strategic advisor and proxy solicitation agent, Laurel Hill Advisory Group, by telephone at 1-877-452-7184 or by email at assistance@laurelhill.com. Aurora Cannabis Inc. (the “Company” or

Pancreatic Cancer Phase 2a Study with Can-Fite’s Namodenoson Achieved Over 50% Enrollment Milestone

(NYSE MKT:CANF),(TASE:CFBI),(TASE:CANF.TA), Primary endpoint is safety; Namodenoson continues to demonstrate a favorable safety profile Ramat Gan, Israel, July 30, 2025 (GLOBE NEWSWIRE) — Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of proprietary small molecule drugs for the treatment of cancer and inflammatory diseases, today announced that it

Pancreatic Cancer Phase 2a Study with Can-Fite’s Namodenoson Achieved Over 50% Enrollment Milestone

Pancreatic Cancer Phase 2a Study with Can-Fite's Namodenoson Achieved Over 50% Enrollment Milestone GlobeNewswire July 30, 2025 Primary endpoint is safety; Namodenoson continues to demonstrate a favorable safety profile Ramat Gan, Israel, July 30, 2025 (GLOBE NEWSWIRE) — Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of proprietary

Survey Finds Medtechs Lack Confidence in Regulatory Data Quality

Veeva MedTech report reveals opportunity to move beyond manual processes for speed and compliance Veeva Systems (NYSE: VEEV) today announced findings from the 2025 Veeva Medtech Regulatory Affairs Benchmark, revealing that 50% of respondents lack full confidence in the completeness of their underlying data for global product registrations. Many organizations are manually reconciling data to

SPRK ILLUMINATES MINILAND AT NEW LEGOLAND® RESORT IN SHANGHAI

SPRK – A Kentucky-based firm known for its innovative work in themed entertainment, is proud to announce the successful completion of the design and installation of immersive lighting for MINILAND at the all-new LEGOLAND® Resort in Shanghai, China. https://mma.prnewswire.com/media/2740969/Miniland.jpg MINILAND, the heart of every LEGOLAND® park, features incredibly detailed LEGO® recreations of iconic cities and

NEOG SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Neogen Corporation Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / July 30, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Neogen Corporation ("Neogen" or "the Company") (NASDAQ:NEOG) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

SRPT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Sarepta Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / July 30, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. ("Sarepta" or "the Company") (NASDAQ:SRPT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

RDDT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Reddit, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / July 30, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Reddit, Inc. ("Reddit" or "the Company") (NYSE:RDDT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

Scroll to Top